Storia in 18 fonti

Landmark pancreatic cancer treatment paves way for targeting other tricky tumors

Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumors will be next

Raccontata da

hindustantimes.com+6 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

scientificamerican.comStai leggendo1 mesi fa

Landmark pancreatic cancer treatment paves way for targeting other tricky tumors

Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumors will be next

originale

Timeline cronologica

domenica 31 maggio 2026·fortune.com
Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for…
domenica 31 maggio 2026·cnn.com
Experimental pill promises new hope for deadly pancreatic cancer | CNN
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…

Landmark pancreatic cancer treatment paves way for targeting other tricky tumors

Confronto fonti

Landmark pancreatic cancer treatment paves way for targeting other tricky tumors

Timeline cronologica

Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune

Experimental pill promises new hope for deadly pancreatic cancer | CNN

Landmark cancer trial shows success against ‘undruggable’ cancer — raising hopes for future treatments

Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival

ASCO26: RevMed’s daraxonrasib presents a turning point for pancreatic cancer - Pharmaceutical Technology

Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial

Il successo di un farmaco contro un tumore "non trattabile" alimenta le speranze per il futuro

Experimental pill offers breakthrough hope in pancreatic cancer fight

Why this new pill for a deadly cancer has doctors excited

Tumore al pancreas, svolta dalla ricerca: il farmaco daraxonrasib raddoppia la sopravvivenza (Calabria 7)

Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival

Landmark cancer trial shows success against ‘undruggable’ cancer — raising hopes for future treatments

Tumore al pancreas, pillola daraxonrasib raddoppia la sopravvivenza: “È una svolta, ho pianto quando ho visto i risultati”

This drug can double survival time for pancreatic cancer patients

Tumore al pancreas, la nuova cura con compresse di daraxonrasib dà speranza: come funziona la molecola

Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial

Revolution Medicines' new cancer pill extends life: ‘Molecular glue’ works, study shows

'Game changer' experimental drug doubles survival time for pancreatic cancer, trial shows | CBC News

ASCO26: RevMed’s daraxonrasib presents a turning point for pancreatic cancer - Pharmaceutical Technology

Scientifically Speaking: A pill takes on pancreatic cancer

Il successo di un farmaco contro un tumore "non trattabile" alimenta le speranze per il futuro

Landmark pancreatic cancer treatment paves way for targeting other tricky tumors

Does Revolution Medicines' pancreatic cancer drug have even greater potential?

umore del pancreas, il farmaco orale che apre una nuova speranza